Ads
related to: heated intraperitoneal chemotherapy
Search results
Results From The WOW.Com Content Network
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a type of hyperthermia therapy used in combination with surgery in the treatment of advanced abdominal cancers. [1] In this procedure, warmed anti-cancer medications are infused and circulated in the peritoneal cavity (abdomen) for a short period of time.
Hot chemotherapy drugs are pumped directly into the peritoneal cavity to kill the cancer cells. [10] Whole-body hyperthermia heats the entire body to temperatures of about 39 to 43 °C (102 to 109 °F), with some advocating even higher temperatures. It is typically used to treat metastatic cancer (cancer that spread to many parts of the body). [6]
The heated chemotherapy (HIPEC) is perfused throughout the abdominal cavity for an hour or two as the last step in the surgery, or ports are installed to allow circulation and/or drainage of the chemicals for one to five days after surgery, known as early postoperative intraperitoneal chemotherapy (EPIC).
Its main developer was Paul Sugarbaker, who is known for the development of cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy, [1] or HIPEC, a treatment alternately referred to as the Sugarbaker Procedure. [2] [3]
A surgeon in Austin, Texas, was in the operating room with a patient when a call came in from the patient’s insurance provider, UnitedHealthcare. She returned the call and shared the story.
This is a KFF Health News story. Preparing cancer patients for difficult decisions is an oncologist's job. At the University of Pennsylvania Health System, doctors are nudged to talk about a ...
Ad
related to: heated intraperitoneal chemotherapy